Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Zebrafish Larvae as a Behavioral Model in Neuropharmacology.

Basnet RM, Zizioli D, Taweedet S, Finazzi D, Memo M.

Biomedicines. 2019 Mar 26;7(1). pii: E23. doi: 10.3390/biomedicines7010023. Review.

2.

Zebrafish disease models in hematology: Highlights on biological and translational impact.

Zizioli D, Mione M, Varinelli M, Malagola M, Bernardi S, Alghisi E, Borsani G, Finazzi D, Monti E, Presta M, Russo D.

Biochim Biophys Acta Mol Basis Dis. 2019 Mar 1;1865(3):620-633. doi: 10.1016/j.bbadis.2018.12.015. Epub 2018 Dec 26. Review.

PMID:
30593895
3.

Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis.

Pagani F, Trivedi A, Khatri D, Zizioli D, Garrafa E, Mitola S, Finazzi D.

Mol Med Rep. 2018 Nov;18(5):4739-4746. doi: 10.3892/mmr.2018.9480. Epub 2018 Sep 13.

PMID:
30221726
4.

Overexpression of Human Mutant PANK2 Proteins Affects Development and Motor Behavior of Zebrafish Embryos.

Khatri D, Zizioli D, Trivedi A, Borsani G, Monti E, Finazzi D.

Neuromolecular Med. 2019 Jun;21(2):120-131. doi: 10.1007/s12017-018-8508-8. Epub 2018 Aug 23.

PMID:
30141000
5.

Comparison of β2-microglobulin serum level between Alzheimer's patients, cognitive healthy and mild cognitive impaired individuals.

Dominici R, Finazzi D, Polito L, Oldoni E, Bugari G, Montanelli A, Scarpini E, Galimberti D, Guaita A.

Biomarkers. 2018 Sep;23(6):603-608. doi: 10.1080/1354750X.2018.1468825. Epub 2018 May 23.

PMID:
29741401
6.

Methylxanthines induce structural and functional alterations of the cardiac system in zebrafish embryos.

Basnet RM, Zizioli D, Guarienti M, Finazzi D, Memo M.

BMC Pharmacol Toxicol. 2017 Nov 15;18(1):72. doi: 10.1186/s40360-017-0179-9.

7.

Clinical Laboratory Automation: A Case Study.

Archetti C, Montanelli A, Finazzi D, Caimi L, Garrafa E.

J Public Health Res. 2017 Jun 16;6(1):881. doi: 10.4081/jphr.2017.881. eCollection 2017 Apr 13.

8.

γ2 and γ1AP-1 complexes: Different essential functions and regulatory mechanisms in clathrin-dependent protein sorting.

Zizioli D, Geumann C, Kratzke M, Mishra R, Borsani G, Finazzi D, Candiello E, Schu P.

Eur J Cell Biol. 2017 Jun;96(4):356-368. doi: 10.1016/j.ejcb.2017.03.008. Epub 2017 Mar 27.

PMID:
28372831
9.

Down-regulation of coasy, the gene associated with NBIA-VI, reduces Bmp signaling, perturbs dorso-ventral patterning and alters neuronal development in zebrafish.

Khatri D, Zizioli D, Tiso N, Facchinello N, Vezzoli S, Gianoncelli A, Memo M, Monti E, Borsani G, Finazzi D.

Sci Rep. 2016 Nov 28;6:37660. doi: 10.1038/srep37660.

10.

Knock-down of pantothenate kinase 2 severely affects the development of the nervous and vascular system in zebrafish, providing new insights into PKAN disease.

Zizioli D, Tiso N, Guglielmi A, Saraceno C, Busolin G, Giuliani R, Khatri D, Monti E, Borsani G, Argenton F, Finazzi D.

Neurobiol Dis. 2016 Jan;85:35-48. doi: 10.1016/j.nbd.2015.10.010. Epub 2015 Oct 18.

11.

The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization.

Ruzzenenti P, Asperti M, Mitola S, Crescini E, Maccarinelli F, Gryzik M, Regoni M, Finazzi D, Arosio P, Poli M.

Biochim Biophys Acta. 2015 Jun;1850(6):1267-73. doi: 10.1016/j.bbagen.2015.02.016. Epub 2015 Mar 5.

PMID:
25749565
12.

A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits.

Maccarinelli F, Pagani A, Cozzi A, Codazzi F, Di Giacomo G, Capoccia S, Rapino S, Finazzi D, Politi LS, Cirulli F, Giorgio M, Cremona O, Grohovaz F, Levi S.

Neurobiol Dis. 2015 Sep;81:119-33. doi: 10.1016/j.nbd.2014.10.023. Epub 2014 Nov 4.

13.

Biology of ferritin in mammals: an update on iron storage, oxidative damage and neurodegeneration.

Finazzi D, Arosio P.

Arch Toxicol. 2014 Oct;88(10):1787-802. doi: 10.1007/s00204-014-1329-0. Epub 2014 Aug 15. Review.

PMID:
25119494
14.

Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.

Levi S, Finazzi D.

Front Pharmacol. 2014 May 7;5:99. doi: 10.3389/fphar.2014.00099. eCollection 2014. Review.

15.

Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity.

Maccarinelli F, Gammella E, Asperti M, Regoni M, Biasiotto G, Turco E, Altruda F, Lonardi S, Cornaghi L, Donetti E, Recalcati S, Poli M, Finazzi D, Arosio P, Cairo G.

J Mol Med (Berl). 2014 Aug;92(8):859-69. doi: 10.1007/s00109-014-1147-0. Epub 2014 Apr 13.

16.

Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo.

Poli M, Asperti M, Naggi A, Campostrini N, Girelli D, Corbella M, Benzi M, Besson-Fournier C, Coppin H, Maccarinelli F, Finazzi D, Arosio P.

Blood. 2014 Mar 6;123(10):1564-73. doi: 10.1182/blood-2013-07-515221. Epub 2014 Jan 7.

17.

Lack of Association between the GPR3 Gene and the Risk for Alzheimer's Disease.

Dominici R, Ronchi M, Galimberti D, Scarpini E, Finazzi D.

Int J Alzheimers Dis. 2011 Apr 7;2011:576143. doi: 10.4061/2011/576143.

18.

Ferritin as an important player in neurodegeneration.

Friedman A, Arosio P, Finazzi D, Koziorowski D, Galazka-Friedman J.

Parkinsonism Relat Disord. 2011 Jul;17(6):423-30. doi: 10.1016/j.parkreldis.2011.03.016. Epub 2011 May 7. Review.

PMID:
21550835
19.

Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo.

Poli M, Girelli D, Campostrini N, Maccarinelli F, Finazzi D, Luscieti S, Nai A, Arosio P.

Blood. 2011 Jan 20;117(3):997-1004. doi: 10.1182/blood-2010-06-289082. Epub 2010 Nov 12.

PMID:
21076043
20.

Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders.

Castiglioni E, Finazzi D, Goldwurm S, Pezzoli G, Forni G, Girelli D, Maccarinelli F, Poli M, Ferrari M, Cremonesi L, Arosio P.

Parkinsons Dis. 2010 Oct 17;2011:827693. doi: 10.4061/2011/827693.

21.

Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients.

Castiglioni E, Finazzi D, Goldwurm S, Levi S, Pezzoli G, Garavaglia B, Nardocci N, Malcovati L, Porta MG, Gallì A, Forni GL, Girelli D, Maccarinelli F, Poli M, Ferrari M, Cremonesi L, Arosio P.

Genet Test Mol Biomarkers. 2010 Dec;14(6):793-6. doi: 10.1089/gtmb.2010.0076. Epub 2010 Oct 12.

PMID:
20939738
22.

Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation.

Poli M, Luscieti S, Gandini V, Maccarinelli F, Finazzi D, Silvestri L, Roetto A, Arosio P.

Haematologica. 2010 Nov;95(11):1832-40. doi: 10.3324/haematol.2010.027003. Epub 2010 Jul 15.

23.

Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation.

Poli M, Derosas M, Luscieti S, Cavadini P, Campanella A, Verardi R, Finazzi D, Arosio P.

Neurobiol Dis. 2010 Aug;39(2):204-10. doi: 10.1016/j.nbd.2010.04.009. Epub 2010 Apr 23.

PMID:
20399859
24.

Mutant ferritin L-chains that cause neurodegeneration act in a dominant-negative manner to reduce ferritin iron incorporation.

Luscieti S, Santambrogio P, Langlois d'Estaintot B, Granier T, Cozzi A, Poli M, Gallois B, Finazzi D, Cattaneo A, Levi S, Arosio P.

J Biol Chem. 2010 Apr 16;285(16):11948-57. doi: 10.1074/jbc.M109.096404. Epub 2010 Feb 16.

25.

APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias.

Lovati C, Galimberti D, Albani D, Bertora P, Venturelli E, Cislaghi G, Guidi I, Fenoglio C, Cortini F, Clerici F, Finazzi D, Forloni G, Scarpini E, Mariani C.

Int J Mol Epidemiol Genet. 2010 Apr 5;1(3):193-200.

26.

Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer's disease.

Vitali M, Venturelli E, Galimberti D, Benerini Gatta L, Scarpini E, Finazzi D.

J Neural Transm (Vienna). 2009 Dec;116(12):1635-41. doi: 10.1007/s00702-009-0324-8. Epub 2009 Oct 14.

PMID:
19826901
27.

Inhibition of heme synthesis alters Amyloid Precursor Protein processing.

Gatta LB, Vitali M, Verardi R, Arosio P, Finazzi D.

J Neural Transm (Vienna). 2009 Jan;116(1):79-88. doi: 10.1007/s00702-008-0147-z. Epub 2008 Nov 11.

PMID:
19002554
28.

Polymorphisms in the LOC387715/ARMS2 putative gene and the risk for Alzheimer's disease.

Gatta LB, Vitali M, Zanola A, Venturelli E, Fenoglio C, Galimberti D, Scarpini E, Finazzi D.

Dement Geriatr Cogn Disord. 2008;26(2):169-74. doi: 10.1159/000151050. Epub 2008 Aug 7.

PMID:
18688167
29.

HFE gene mutations in a population of Italian Parkinson's disease patients.

Biasiotto G, Goldwurm S, Finazzi D, Tunesi S, Zecchinelli A, Sironi F, Pezzoli G, Arosio P.

Parkinsonism Relat Disord. 2008;14(5):426-30. doi: 10.1016/j.parkreldis.2007.10.011. Epub 2008 Mar 5.

PMID:
18325820
30.

Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.

Poli M, Gatta LB, Lovati C, Mariani C, Galimberti D, Scarpini E, Biunno I, Musicco M, Dominici R, Albertini A, Finazzi D.

Neurobiol Aging. 2008 Oct;29(10):1494-501. Epub 2007 Apr 26.

PMID:
17466415
31.

Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease.

Venturelli E, Galimberti D, Fenoglio C, Lovati C, Finazzi D, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Forloni G, Bresolin N, Scarpini E.

Neurosci Lett. 2006 Aug 14;404(1-2):217-21. Epub 2006 Jun 19.

PMID:
16787707
32.

A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease.

Saltini G, Dominici R, Lovati C, Cattaneo M, Michelini S, Malferrari G, Caprera A, Milanesi L, Finazzi D, Bertora P, Scarpini E, Galimberti D, Venturelli E, Musicco M, Adorni F, Mariani C, Biunno I.

Neurosci Lett. 2006 May 1;398(1-2):53-8. Epub 2006 Jan 10.

PMID:
16412574
33.

DNA sequence variations in the prolyl isomerase Pin1 gene and Alzheimer's disease.

Poli M, Gatta LB, Dominici R, Lovati C, Mariani C, Albertini A, Finazzi D.

Neurosci Lett. 2005 Dec 2;389(2):66-70.

PMID:
16095818
34.

Apolipoprotein E haplotyping by denaturing high-performance liquid chromatography.

Poli M, Gatta LB, Dominici R, Lovati C, Mariani C, Albertini A, Finazzi D.

Clin Chem Lab Med. 2005;43(5):512-8.

PMID:
15899673
35.

Arginase pathway in human endothelial cells in pathophysiological conditions.

Bachetti T, Comini L, Francolini G, Bastianon D, Valetti B, Cadei M, Grigolato P, Suzuki H, Finazzi D, Albertini A, Curello S, Ferrari R.

J Mol Cell Cardiol. 2004 Aug;37(2):515-23.

PMID:
15276021
36.

Association analysis between anterior-pharynx defective-1 genes polymorphisms and Alzheimer's disease.

Poli M, Gatta LB, Archetti S, Padovani A, Albertini A, Finazzi D.

Neurosci Lett. 2003 Oct 23;350(2):77-80.

PMID:
12972157
37.

Inhibition of energy metabolism down-regulates the Alzheimer related presenilin 2 gene.

Ghidoni R, Gasparini L, Alberici A, Benussi L, Barbiero L, Mazzoli F, Nicosia F, Finazzi D, Benerini Gatta L, Albertini A, Zanetti O, Binetti G.

J Neural Transm (Vienna). 2003 Sep;110(9):1029-39.

PMID:
12938025
38.

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus.

Gatta LB, Albertini A, Ravid R, Finazzi D.

Neuroreport. 2002 Nov 15;13(16):2031-3.

PMID:
12438920
39.

Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia.

Zanella I, Rossi G, Finazzi D, Capucci A, Albertini A, Cariani E.

Haematologica. 2001 Mar;86(3):318-9. No abstract available.

40.

Presenilin 1 protein directly interacts with Bcl-2.

Alberici A, Moratto D, Benussi L, Gasparini L, Ghidoni R, Gatta LB, Finazzi D, Frisoni GB, Trabucchi M, Growdon JH, Nitsch RM, Binetti G.

J Biol Chem. 1999 Oct 22;274(43):30764-9.

41.

Overexpression of wild-type and mutant ARF1 and ARF6: distinct perturbations of nonoverlapping membrane compartments.

Peters PJ, Hsu VW, Ooi CE, Finazzi D, Teal SB, Oorschot V, Donaldson JG, Klausner RD.

J Cell Biol. 1995 Mar;128(6):1003-17.

42.

Aluminum fluoride acts on the reversibility of ARF1-dependent coat protein binding to Golgi membranes.

Finazzi D, Cassel D, Donaldson JG, Klausner RD.

J Biol Chem. 1994 May 6;269(18):13325-30.

43.
44.

Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein.

Donaldson JG, Finazzi D, Klausner RD.

Nature. 1992 Nov 26;360(6402):350-2.

PMID:
1448151
45.

Modulating secretion of antibodies.

Fra AM, Alberini C, Bet P, Finazzi D, Valetti C, Sitia R.

Ann Biol Clin (Paris). 1991;49(5):283-6.

PMID:
1928844

Supplemental Content

Loading ...
Support Center